Developer docs
API playgroundTry for free, no card

Search company profiles

Ennocure Medtech

Full company profile

uuid00vlcno

Namestring
Ennocure Medtech
Legal namestring
ENNOCURE GmbH
Websiteurl
ennocure.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Ennocure Medtech (legally ENNOCURE GmbH) is an Austrian medical technology company developing the Ennocure Smart Patch, a bioelectronic wound dressing that combines microcurrent stimulation with embedded continuous-monitoring sensors for the treatment of chronic wounds. The product architecture pairs a silicone foam dressing with electronics that deliver controlled electric fields intended to orchestrate keratinocyte and fibroblast migration and disrupt bacterial biofilms, while integrated sensors track electrical resistance and ionic activity 24/7 to provide non-invasive insight into healing progression. The system is sold as a unified offering: the Smart Patch device, a patient-facing mobile application, and a clinical platform with AI-driven alerts that flag deviations from expected healing patterns for remote clinical oversight.

The company targets two primary segments: chronic wound patients—specifically those with diabetic foot ulcers and venous leg ulcers whose natural 'current of injury' is exhausted and who require continuous at-home treatment and monitoring—and the healthcare providers who oversee their care between clinic visits. The go-to-market approach is direct and sales-led, relying on a contact form on ennocure.com to capture inquiries from patients and clinicians rather than through disclosed distribution partners, payer contracts, or named reference customers. No pricing, reimbursement strategy, or distributor network has been disclosed in the source material.

Ennocure is pre-revenue and the Smart Patch is explicitly described as under development and not approved for clinical use. The company is privately held as an Austrian GmbH, has a nine-person international team led by Dr. Manuela Hod (CEO) and Dr. Christoph Huber (COO), and has not publicly disclosed any funding rounds, partnerships, regulatory submissions, certifications, or named customers. Its registered office is in Klagenfurt am Wörthersee, Austria, and it maintains an Israeli phone contact line.

Short descriptiontext

Ennocure Medtech is an Austrian medtech company developing a bioelectronic smart wound patch that combines microcurrent therapy with continuous AI-driven sensor monitoring, targeting chronic wound patients and their healthcare providers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersKlagenfurt, Austria
HQ citystring
Klagenfurt
HQ countrystring
Austria
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
smart wound care, microcurrent therapy, chronic wound management, bioelectronic medicine, remote patient monitoring
Industry3 codes
PRIMARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLAAAGAG
Wound Healing & Skin Regeneration (advanced dressings, skin substitutes)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAKACAN
Wound Care & Ulcer Management
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Smart Wound Care Devices
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Smart Wound Patch Device
TypeHardware Sales
Description

Sale of the Ennocure Smart Patch device which delivers microcurrent treatment with integrated monitoring capabilities. The product combines hardware (patch with embedded electronics), software (patient app and clinical platform), and consumable elements (wound dressing). Pre-revenue as product is under development and not yet approved for clinical use.

ennocure.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Ennocure develops the Ennocure Smart Patch, a bioelectronic wound dressing that combines silicone foam dressing materials with embedded microcurrent technology and integrated sensors. The system delivers controlled electrical stimulation to reactivate stalled healing in chronic wounds while continuously monitoring wound conditions 24/7, with data accessible to patients via a mobile app and to clinicians via a clinical platform featuring AI-driven alerts.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Over $90B in annual costs driven by chronic wounds globally
+1 more record
Product overview1 text field

Ennocure offers a unified smart wound care system combining the Ennocure Smart Patch (a microcurrent-enabled silicone foam dressing with embedded sensors) with the Patient App and Clinical Platform. The Smart Patch delivers continuous electrical stimulation to reactivates stalled healing in chronic wounds while sensors monitor wound conditions 24/7. The Patient App provides real-time data to patients at home, while the Clinical Platform enables healthcare providers to remotely oversee patients and receive AI-driven alerts for timely interventions.

Product and service1 record
1Ennocure Smart Patch
CategoryBioelectronic Wound Care Device
Description

An integrated smart wound care system designed for chronic wound patients (such as those with diabetic foot ulcers and venous leg ulcers) for at-home use. The system combines a silicone foam wound dressing with embedded microcurrent technology, integrated sensors for continuous 24/7 monitoring of electrical resistance and ionic activity, a patient-facing mobile app for real-time wound tracking, and a clinical platform providing healthcare providers with AI-driven alerts and remote oversight capabilities.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Canadian commercial-stage company selling handheld fluorescence imaging devices (i:X, DX) that detect bacterial load in chronic wounds in real time. Most directly comparable as a digital wound-care technology player bringing objective, point-of-care data to wound assessment — Ennocure's continuous sensor approach competes in the same 'objective wound data' category.

TypeBroad incumbent
Description

Danish medtech serving wound care (Biatain, Comfeel) and ostomy customers globally. Comparable as a premium wound-dressing supplier with similar end users; Ennocure's connected platform is the key point of product divergence.

TypeEmerging player
Description

US-listed regenerative medicine company (Apligraf, Dermagraft, PuraPly) selling skin substitutes and advanced biologics for chronic wounds. Comparable as a non-dressing advanced therapy targeting the same stalled-healing indications (DFU, VLU), though its mechanism (cellular matrices) differs from Ennocure's microcurrent approach.

TypeBroad incumbent
Description

Spun off from 3M in 2024, Solventum retains the legacy 3M wound-care franchise including V.A.C. NPWT systems and advanced dressings. It is the most entrenched NPWT competitor and the incumbent most likely to bundle monitoring/AI features into existing V.A.C. platforms.

TypeDirect peer
Description

Canadian digital health company offering a smartphone-based AI wound imaging and measurement platform used by home-health agencies and wound clinics. Comparable as a connected wound-care software play; Swift focuses on imaging while Ennocure focuses on embedded biosensors, but both sell into remote wound monitoring workflows.

TypeBroad incumbent
Description

Global medical-device leader with a substantial Advanced Wound Management portfolio (ALLEVYN dressings, PICO single-use NPWT, VERSAJET, RENASYS). Ennocure competes for the same chronic-wound budget at hospitals, wound clinics, and home-care, though Smith & Nephew does not currently offer a connected microcurrent dressing.

TypeBroad incumbent
Description

UK-listed medtech with a dedicated Advanced Wound Care franchise (AQUACEL, FoamLite, InnovaMatrix). Targets the same diabetic foot ulcer / venous leg ulcer patient population and overlapping clinician call points; competing primarily on dressing technology rather than connected therapeutics.

TypeEmerging player
Description

US-listed developer of placental tissue allografts (EpiFix, AmnioFix) used in chronic wound and surgical recovery. Comparable as an emerging advanced-therapy wound-care company targeting diabetic foot ulcers and venous leg ulcers with a mechanism different from microcurrent but competing for the same reimbursement and prescriber mindshare.

TypeBroad incumbent
Description

Swedish private company and one of the world's largest advanced wound-care suppliers (Mepilex Border, Mepitel, Exufiber). Comparable as a high-end silicone-foam dressing provider targeting the same chronic-wound prescribers; Mölnlycke lacks an integrated electrotherapy/monitoring platform today.

TypeDirect peer
Description

US-listed (MDIT on Nasdaq prior to planned uplisting) developer of the DeepView AI wound-healing assessment platform, combining multispectral imaging with predictive AI to forecast burn and chronic-wound healing. Closest publicly-traded peer in AI-driven wound assessment; targets similar clinical decision-support use cases Ennocure's Clinical Platform addresses.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ennocure Medtech

Smart Wound Care Devicesennocure.com

Ennocure Medtech is an Austrian medtech company developing a bioelectronic smart wound patch that combines microcurrent therapy with continuous AI-driven sensor monitoring, targeting chronic wound patients and their healthcare providers.

What Ennocure Medtech does

Ennocure Medtech (legally ENNOCURE GmbH) is an Austrian medical technology company developing the Ennocure Smart Patch, a bioelectronic wound dressing that combines microcurrent stimulation with embedded continuous-monitoring sensors for the treatment of chronic wounds. The product architecture pairs a silicone foam dressing with electronics that deliver controlled electric fields intended to orchestrate keratinocyte and fibroblast migration and disrupt bacterial biofilms, while integrated sensors track electrical resistance and ionic activity 24/7 to provide non-invasive insight into healing progression. The system is sold as a unified offering: the Smart Patch device, a patient-facing mobile application, and a clinical platform with AI-driven alerts that flag deviations from expected healing patterns for remote clinical oversight.

The company targets two primary segments: chronic wound patients—specifically those with diabetic foot ulcers and venous leg ulcers whose natural 'current of injury' is exhausted and who require continuous at-home treatment and monitoring—and the healthcare providers who oversee their care between clinic visits. The go-to-market approach is direct and sales-led, relying on a contact form on ennocure.com to capture inquiries from patients and clinicians rather than through disclosed distribution partners, payer contracts, or named reference customers. No pricing, reimbursement strategy, or distributor network has been disclosed in the source material.

Ennocure is pre-revenue and the Smart Patch is explicitly described as under development and not approved for clinical use. The company is privately held as an Austrian GmbH, has a nine-person international team led by Dr. Manuela Hod (CEO) and Dr. Christoph Huber (COO), and has not publicly disclosed any funding rounds, partnerships, regulatory submissions, certifications, or named customers. Its registered office is in Klagenfurt am Wörthersee, Austria, and it maintains an Israeli phone contact line.

Ennocure Medtech firmographics

Firmographics
Name
Ennocure Medtech
Legal name
ENNOCURE GmbH
Website
https://ennocure.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
Ennocure Medtech is an Austrian medtech company developing a bioelectronic smart wound patch that combines microcurrent therapy with continuous AI-driven sensor monitoring, targeting chronic wound patients and their healthcare providers.
Ownership category
akta.pro rank

Ennocure Medtech industry classification

Industry
Product category
Smart Wound Care Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLAAAGAG
Wound Healing & Skin Regeneration (advanced dressings, skin substitutes)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAKACAN
Wound Care & Ulcer Management

Keywords

  • Smart wound care
  • Microcurrent therapy
  • Chronic wound management
  • Bioelectronic medicine
  • Remote patient monitoring

Where Ennocure Medtech is headquartered

Location

Headquarters

HQ city
Klagenfurt
HQ country
Austria
HQ region
Europe

Offices1 record

Markets served

Ennocure Medtech business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

  1. Smart Wound Patch Device: Sale of the Ennocure Smart Patch device which delivers microcurrent treatment with integrated monitoring capabilities. The product combines hardware (patch with embedded electronics), software (patient app and clinical platform), and consumable elements (wound dressing). Pre-revenue as product is under development and not yet approved for clinical use.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Ennocure Medtech product offering

Product offering

Core offering

Ennocure develops the Ennocure Smart Patch, a bioelectronic wound dressing that combines silicone foam dressing materials with embedded microcurrent technology and integrated sensors. The system delivers controlled electrical stimulation to reactivate stalled healing in chronic wounds while continuously monitoring wound conditions 24/7, with data accessible to patients via a mobile app and to clinicians via a clinical platform featuring AI-driven alerts.

Product overview

Ennocure offers a unified smart wound care system combining the Ennocure Smart Patch (a microcurrent-enabled silicone foam dressing with embedded sensors) with the Patient App and Clinical Platform. The Smart Patch delivers continuous electrical stimulation to reactivates stalled healing in chronic wounds while sensors monitor wound conditions 24/7. The Patient App provides real-time data to patients at home, while the Clinical Platform enables healthcare providers to remotely oversee patients and receive AI-driven alerts for timely interventions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ennocure Smart Patch An integrated smart wound care system designed for chronic wound patients (such as those with diabetic foot ulcers and venous leg ulcers) for at-home use. The system combines a silicone foam wound dressing with embedded microcurrent technology, integrated sensors for continuous 24/7 monitoring of electrical resistance and ionic activity, a patient-facing mobile app for real-time wound tracking, and a clinical platform providing healthcare providers with AI-driven alerts and remote oversight capabilities.

Quantifiable outcome

  • Over $90B in annual costs driven by chronic wounds globally
  • +1 more outcomes

Companies that use Ennocure Medtech

Customer profile

Segments2 records

Ideal customer profiles2 records

Ennocure Medtech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Ennocure Medtech partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights5 records

Ennocure Medtech competitors and assessment

Company assessment

Direct peers

  • MolecuLight: Canadian commercial-stage company selling handheld fluorescence imaging devices (i:X, DX) that detect bacterial load in chronic wounds in real time. Most directly comparable as a digital wound-care technology player bringing objective, point-of-care data to wound assessment — Ennocure's continuous sensor approach competes in the same 'objective wound data' category.
  • Swift Medical: Canadian digital health company offering a smartphone-based AI wound imaging and measurement platform used by home-health agencies and wound clinics. Comparable as a connected wound-care software play; Swift focuses on imaging while Ennocure focuses on embedded biosensors, but both sell into remote wound monitoring workflows.
  • Spectral AI: US-listed (MDIT on Nasdaq prior to planned uplisting) developer of the DeepView AI wound-healing assessment platform, combining multispectral imaging with predictive AI to forecast burn and chronic-wound healing. Closest publicly-traded peer in AI-driven wound assessment; targets similar clinical decision-support use cases Ennocure's Clinical Platform addresses.

Broad incumbents

  • Coloplast: Danish medtech serving wound care (Biatain, Comfeel) and ostomy customers globally. Comparable as a premium wound-dressing supplier with similar end users; Ennocure's connected platform is the key point of product divergence.
  • Solventum (3M Health Care spinoff): Spun off from 3M in 2024, Solventum retains the legacy 3M wound-care franchise including V.A.C. NPWT systems and advanced dressings. It is the most entrenched NPWT competitor and the incumbent most likely to bundle monitoring/AI features into existing V.A.C. platforms.
  • Smith & Nephew: Global medical-device leader with a substantial Advanced Wound Management portfolio (ALLEVYN dressings, PICO single-use NPWT, VERSAJET, RENASYS). Ennocure competes for the same chronic-wound budget at hospitals, wound clinics, and home-care, though Smith & Nephew does not currently offer a connected microcurrent dressing.
  • Convatec: UK-listed medtech with a dedicated Advanced Wound Care franchise (AQUACEL, FoamLite, InnovaMatrix). Targets the same diabetic foot ulcer / venous leg ulcer patient population and overlapping clinician call points; competing primarily on dressing technology rather than connected therapeutics.
  • Mölnlycke Health Care: Swedish private company and one of the world's largest advanced wound-care suppliers (Mepilex Border, Mepitel, Exufiber). Comparable as a high-end silicone-foam dressing provider targeting the same chronic-wound prescribers; Mölnlycke lacks an integrated electrotherapy/monitoring platform today.

Emerging players

  • Organogenesis: US-listed regenerative medicine company (Apligraf, Dermagraft, PuraPly) selling skin substitutes and advanced biologics for chronic wounds. Comparable as a non-dressing advanced therapy targeting the same stalled-healing indications (DFU, VLU), though its mechanism (cellular matrices) differs from Ennocure's microcurrent approach.
  • MiMedx: US-listed developer of placental tissue allografts (EpiFix, AmnioFix) used in chronic wound and surgical recovery. Comparable as an emerging advanced-therapy wound-care company targeting diabetic foot ulcers and venous leg ulcers with a mechanism different from microcurrent but competing for the same reimbursement and prescriber mindshare.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Ennocure Medtech social profiles

Digital presence

Ennocure Medtech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ennocure Medtech leadership team

Management profile

Number of profiles

Profiles9 records

Ennocure Medtech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ennocure Medtech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ennocure Medtech

What does Ennocure Medtech do?

Ennocure develops the Ennocure Smart Patch, a bioelectronic wound dressing that combines silicone foam dressing materials with embedded microcurrent technology and integrated sensors. The system delivers controlled electrical stimulation to reactivate stalled healing in chronic wounds while continuously monitoring wound conditions 24/7, with data accessible to patients via a mobile app and to clinicians via a clinical platform featuring AI-driven alerts.

Is Ennocure Medtech a public or private company?

Ennocure Medtech is a private company. It is classified as unknown and is currently operating.

When was Ennocure Medtech founded?

Ennocure Medtech was founded in 2022. It employs 1 to 10 people.

Where is Ennocure Medtech based?

Ennocure Medtech is headquartered in Klagenfurt, Austria, in the Europe region.

How does Ennocure Medtech make money?

One revenue line is on record: smart Wound Patch Device.

Who are Ennocure Medtech's main competitors?

Direct peers on record are MolecuLight, Swift Medical and Spectral AI. Broad incumbents are Coloplast, Solventum (3M Health Care spinoff), Smith & Nephew, Convatec and Mölnlycke Health Care. Emerging players are Organogenesis and MiMedx.

Does Ennocure Medtech have an API?

No public API is recorded for Ennocure Medtech.

What industry is Ennocure Medtech in?

Ennocure Medtech's product category is Smart Wound Care Devices. Its primary akta.pro industry code is HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring, with a secondary code of HLAAAGAG, Wound Healing & Skin Regeneration (advanced dressings, skin substitutes). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals